Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma

International Journal of Molecular Medicine

Volumn 17, Issue 1, 2006, Pages 159-170

  Fatima, Sarwat ^a   Chui, Chung H ^a,b,c   Tang, Wing K ^a   Hui, Kin S ^a   Au, Ho W ^a   Li, Wing Y ^a   Wong, Mei M ^a   Cheung, Filly ^a   Tsao, S W ^d   Lam, King Y ^e   Beh, Philip S L ^d   Wong, John ^d   Law, Simon ^d   Srivastava, Gopesh ^d   Ho, Kwok P ^a   Chan, Albert S C ^a,b   Tang, Johnny C O ^a,b,d  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

Esophageal squamous cell carcinoma; Gene over expression; Transforming capacity; Tumorigenicity

Indexed keywords

JS 1 PROTEIN, HUMAN; JS 2 PROTEIN, HUMAN; JS-1 PROTEIN, HUMAN; JS-2 PROTEIN, HUMAN; TUMOR PROTEIN;

AGED; ANIMAL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME 5; DNA SEQUENCE; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 5; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NIH 3T3 CELLS; SEQUENCE ANALYSIS, DNA;

EID: 33644873362     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.1.159     Document Type: Article

References (43)

1. Si HX, Tsao SW, Poon CS, Wang LD, Wong YC and Cheung AL: Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 103: 496-500, 2003. (Pubitemid 36020224)
2. Koshy M, Esiashvilli N, Landry JC, Thomas CR Jr and Matthews RH: Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist 9: 137-146, 2004. (Pubitemid 38452113)
3. Yen CC, Chen YJ, Chen JT, et al: Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 92: 2769-2777, 2001.
4. Kwong D, Lam A, Guan X, Law S, Tai A, Wong J and Sham J: Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 35: 309-316, 2004. (Pubitemid 38339604)
5. Lam AK: Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33: 71-90, 2000. (Pubitemid 30085471)
6. Syrjänen KJ: HPV infections and oesophageal cancer. J Clin Pathol 55: 721-728, 2002.
7. Shai R, Shi T, Kremen TJ, et al: Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22: 4918-4923, 2003. (Pubitemid 36981282)
8. Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF and Gardiner RA: Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int J Cancer 100: 228-237, 2002. (Pubitemid 34666199)
9. Tang JC, Wan TS, Wong N, et al: Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet Cytogenet 124: 36-41, 2001.
10. Hu YC, Lam KY, Law SY, et al: Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 135: 120-127, 2002.
11. Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284, 1992.
12. Miyazono F, Metzger R, Warnecke-Eberz U, et al: Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer 91: 666-672, 2004.
13. Jin W, Wu L, Liang K, Liu B, Lu Y and Fan Z: Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells. Br J Cancer 89: 185-191, 2003.
14. Ma T, Zhu ZG, Ji YB, et al: Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine. World J Gastroenterol 10: 172-176, 2004.
15. Cowley S, Paterson H, Kemp P and Marshall CJ: Activation of MAP kinase is necessary and sufficient for PC 12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
16. Kozak M: An analysis of 5'-non-coding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148, 1987.
17. Zhou C, Liu S, Zhou X, et al: Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 113: 891-898, 2005.
18. Adelaide J, Monges G, Derderian C, Seitz JF and Birnbaum D: Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71: 64-68, 1995.
19. Miyazaki T, Kato H, Fukuchi M, Nakajima M and Kuwano H: EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103: 657-663, 2003.
20. Hamburger A and Salmon SE: Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846-854, 1977. (Pubitemid 8208477)
21. Freedman VH and Shin SI: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359, 1974.
22. Shin SI, Freedman VH, Risser R and Pollack R: Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 72: 4435-4439, 1975.
23. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 98: 5043-5048, 2001.
24. Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H and Kuwano H: Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma. Anticancer Res 24: 777-783, 2004. (Pubitemid 38625021)
25. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G and Pagano M: Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci USA 98: 2515-2520, 2001. (Pubitemid 32209513)
26. Zhang R, Wang H and Agrawal S: Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms. Curr Cancer Drug Targets 5: 43-49, 2005. (Pubitemid 40321799)
27. Morgan RJ, Newcomb PV, Hardwick RH and Alderson D: Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma. Eur J Surg Oncol 25: 364-367, 1999.
28. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003.
29. Ebihara Y, Miyamoto M, Shichinohe T, et al: Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Dis Esophagus 17: 150-154, 2004.
30. Itami A, Shimada Y, Watanabe G and Imamura M: Prognostic value of p27(Kip1) and cyclin D1 expression in esophageal cancer. Oncology 7: 311-317, 1999.
31. Faried A, Nakajima M, Sohda M, Miyazaki T, Kato H and Kuwano H: Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma. Eur J Surg Oncol 31: 410-414, 2005. (Pubitemid 40521309)
32. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T and Kano M: Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80: 1281-1288, 1999. (Pubitemid 29264093)
33. Lu J, Hu G, Wang X, Wu M and Liu Z: Cloning and characterization of a novel gene EC97 associated with human esophageal squamous cell carcinoma. Int J Mol Med 11: 243-247, 2003.
34. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H and Croce CM: Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 21: 5024-5030, 2002.
35. Yu HP, Xu SQ, Lu WH, Li YY, Li F, Wang XL and Su YH: Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus. J Surg Oncol 86: 99-104, 2004.
36. Xiong XD, Xu LY, Shen ZY, Cai WJ, Luo JM, Han YL and Li EM: Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry. World J Gastroenterol 8: 777-781, 2002.
37. Oka R, Sasagawa T, Ninomiya I, Miwa K, Tanii H and Saijoh K: Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma. Eur J Cancer 37: 1158-1165, 2001.
38. Ueno T, Tangoku A, Yoshino S, et al: Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 8: 526-533, 2002.
39. Miyazaki T, Kato H, Nakajima M, et al: FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89: 140-145, 2003.
40. Chui CH, Lau FY, Tang JCO, et al: Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. Int J Mol Med 16: 337-341, 2005.
41. Chui CH, Lau FY, Chan ASC, et al: Gleditsia sinensis fruit extract induced apoptosis involves changes of reactive oxygen species level, mitochondrial membrane depolarization and caspase 3 activation. Int J Mol Med 15: 539-543, 2005.
42. Teo ITN, Tang JCO, Chui CH, et al: Superoxide anion is involved in the early apoptosis mediated by Gleditsia sinensis extract. Int J Mol Med 13: 909-913, 2004.
43. Chui CH, Tang JCO, Lau FY, et al: Gleditsia sinensis fruit extract induced growth inhibition involves basic fibroblast growth factor and nitric oxide. Int J Mol Med 13: 169-173, 2004.